Видео

The Daily Edition on Channel 7 interviews Emerge Australia CEO Dr Heidi Nicholl, 11 June 2019

Dr Ruud Raijmakers - Radboud University Medical Center, Netherlands

Dr Mark Donohoe - Mosman Integrative Medicine, Australia

Dr Heidi Nicholl Emerge Australia CEO and Professor Paul Fisher on ABC Radio Melbourne on Mon 11th March.

Dr Eliana Lacerda - London School of Hygeine & Tropical Medicine, UK

Abstract Presentation: Differences Between Immunophenotype of B Cells from Healthy Controls & Patients with ME/CFS Dr Geraldine Cambridge - University College of London, UK

Dr Ron Davis - Stanford University School of Medicine, USA

Dr Heidi Nicholl, CEO, Emerge Australia

Day 1 Report

Mapping Fatigue in the Brain in Paediatric ME/CFS

ME/CFS: Clinical Experience 2

Empathic Design & ME/CFS

Metabolic Traps in ME/CFS

Dr Alain Moreau - Université de Montréal, Canada

Dr Heidi Nicholl, CEO, Emerge Australia

Dr Jarred Younger - University of Birmingham, USA

From Gene Expression to Multi-system Regulation: Identifying Optimal Treatment Courses for Complex Chronic Illnesses Dr Travis Craddock - Nova South Eastern University, USA

Australian Clinical Panel - Dr Mark Donohoe, Dr Bruce Wauchope, Dr Don Lewis, Dr Nicole Phllips

Rethinking Diagnostic Reference Intervals for ME/CFS via Machine Learning & the Utility of Activin B to Assess Symptom Severity Dr Brett Lidbury - Australian National University

Targeted Molecular Diagnosis of ME/CFS - the Devil is in the Details

Establishing New Mechanistic & Diagnostic Paradigms for ME/CFS

An Omic Analysis of ME/CFS - an Assessment of Potential Mechanisms

Symposium Opening - Dr Heidi Nicholl, CEO, Emerge Australia

Specific Mitochondrial Respiratory Defects & Compensatory Changes in ME/CFS Patient Cells

Brain Stem Myelination & MRI Changes in ME/CFS

The Severely Ill Patient Study of ME/CFS

ME/CFS Research in Human-Computer Interaction

Day 2 Report

Using N-of-1 Methods to Identify Patterns & Predictors of ME/CFS Symptom Exacerbations